|
influenza |
24 |
|
humans |
20 |
|
sars-cov-2 |
19 |
|
covid-19 |
16 |
|
respiratory system - virology |
16 |
|
cells, cultured |
15 |
|
cytokines - metabolism |
15 |
|
mers-cov |
14 |
|
avian |
13 |
|
conjunctiva - virology |
13 |
|
coronavirus |
13 |
|
organ culture techniques |
13 |
|
viral tropism |
13 |
|
bronchi - cytology |
12 |
|
immunity, innate |
12 |
|
influenza a virus, h1n1 subtype - metabolism |
12 |
|
influenza, human - virology |
12 |
|
zoonosis |
12 |
|
africa |
11 |
|
cytokines - immunology |
11 |
|
acute lung injury |
10 |
|
adaptor proteins, signal transducing - genetics - immunology - metabolism |
10 |
|
alveolar epithelial cells |
10 |
|
animals |
10 |
|
conjunctiva |
10 |
|
dead-box rna helicases - genetics - immunology - metabolism |
10 |
|
epithelial cells - immunology - metabolism |
10 |
|
h7n9 |
10 |
|
influenza a virus, h1n1 subtype - genetics - growth & development - pathogenicity |
10 |
|
influenza a virus, h1n1 subtype - genetics - immunology |
10 |
|
influenza a virus, h1n2 subtype - genetics - growth & development - pathogenicity |
10 |
|
influenza a virus, h5n1 subtype - genetics - immunology |
10 |
|
influenza a virus, h5n1 subtype - metabolism |
10 |
|
influenza, human - immunology - metabolism - virology |
10 |
|
influenza, human - metabolism - transmission |
10 |
|
interferon regulatory factor-3 - metabolism |
10 |
|
ip-10 |
10 |
|
janus kinases - immunology |
10 |
|
macrophages - immunology - metabolism |
10 |
|
mesenchymal stromal cells |
10 |
|
nf-kappa b - metabolism |
10 |
|
p38 mitogen-activated protein kinases - metabolism |
10 |
|
paracrine communication - immunology |
10 |
|
pulmonary alveoli - immunology - metabolism |
10 |
|
reassortant viruses - isolation & purification |
10 |
|
receptor, interferon alpha-beta - immunology |
10 |
|
receptors, cell surface - metabolism |
10 |
|
respiratory mucosa - virology |
10 |
|
rna, small interfering - genetics |
10 |
|
rna, viral - metabolism |
10 |
|
signal transduction |
10 |
|
swine |
10 |
|
toll-like receptor 3 - metabolism |
10 |
|
up-regulation |
10 |
|
virulence |
10 |
|
virus attachment |
10 |
|
alveolar fluid clearance |
9 |
|
pathogenesis |
9 |
|
2009 pandemic h1n1 influenza virus |
8 |
|
autopsy |
8 |
|
bronchi - immunology - pathology |
8 |
|
characterization |
8 |
|
chemokines |
8 |
|
coronaviruses |
8 |
|
influenza a virus, h5n1 subtype - immunology |
8 |
|
innate host responses |
8 |
|
phenotype |
8 |
|
pulmonary alveoli - immunology |
8 |
|
respiratory mucosa - immunology - pathology |
8 |
|
swine influenza virus |
8 |
|
tropism |
8 |
|
china |
7 |
|
dna-directed dna polymerase - genetics - metabolism |
7 |
|
evolution |
7 |
|
ferrets - virology |
7 |
|
gene expression regulation, viral - physiology |
7 |
|
hemagglutinin glycoproteins, influenza virus - metabolism |
7 |
|
hemagglutinins - genetics - metabolism |
7 |
|
hong kong |
7 |
|
influenza a |
7 |
|
influenza a virus, h1n1 subtype - enzymology - genetics - physiology |
7 |
|
influenza a virus, h5n1 subtype - classification - genetics |
7 |
|
mers |
7 |
|
neuraminidase - metabolism |
7 |
|
orthomyxoviridae infections - epidemiology - transmission - virology |
7 |
|
viral genes |
7 |
|
airway epithelial cells |
6 |
|
cigarette smoking |
6 |
|
cytokine |
6 |
|
dogs |
6 |
|
ex vivo |
6 |
|
explants |
6 |
|
hpai |
6 |
|
immunocompromised host - immunology |
6 |
|
influenza a virus |
6 |
|
influenza a virus, h1n1 subtype - physiology |
6 |
|
influenza, human - immunology |
6 |
|
nsp6 |
6 |
|
pulmonary alveoli - immunology - virology |
6 |
|
risk assessment |
6 |
|
sars |
6 |
|
sars-cov |
6 |
|
virus evolution |
6 |
|
adaptation, biological |
5 |
|
antiviral agents - pharmacology |
5 |
|
cell polarity |
5 |
|
clade 2.3.4.4 |
5 |
|
cyclosporine |
5 |
|
emetine |
5 |
|
endothelial cells - immunology - virology |
5 |
|
epithelial cells - immunology - virology |
5 |
|
ex vivo explants |
5 |
|
fomite |
5 |
|
hpai h5nx |
5 |
|
indirubin |
5 |
|
influenza a virus - enzymology - genetics |
5 |
|
influenza a virus - genetics - metabolism - physiology |
5 |
|
influenza a virus, h1n1 subtype - immunology - pathogenicity |
5 |
|
influenza a virus, h5n1 subtype - drug effects |
5 |
|
influenza a virus, h9n2 subtype - genetics - pathogenicity |
5 |
|
influenza in birds - enzymology |
5 |
|
influenza, human - prevention and control - virology |
5 |
|
interferons - metabolism - pharmacology |
5 |
|
lopinavir |
5 |
|
lung - cytology - drug effects - virology |
5 |
|
lung - drug effects - metabolism - virology |
5 |
|
macrophages |
5 |
|
mammals - virology |
5 |
|
middle east respiratory syndrome coronavirus (mers-cov) |
5 |
|
pneumocytes |
5 |
|
recombinant fusion proteins - pharmacology |
5 |
|
remdesivir |
5 |
|
ritonavir |
5 |
|
rna replicase - genetics - metabolism |
5 |
|
signal transduction - physiology |
5 |
|
tissue tropism |
5 |
|
transmission |
5 |
|
type i interferon |
5 |
|
viral nonstructural proteins - genetics - metabolism - physiology |
5 |
|
viral proteins - genetics - metabolism |
5 |
|
virulence factors - genetics - metabolism |
5 |
|
adolescent |
4 |
|
antiviral agents - pharmacokinetics - pharmacology |
4 |
|
apoptosis |
4 |
|
avian influenza h5n1 virus |
4 |
|
bronchial epithelial cells |
4 |
|
cell cycle |
4 |
|
cell cycle arrest |
4 |
|
cell function |
4 |
|
cell isolation |
4 |
|
cell migration |
4 |
|
child |
4 |
|
coronavirus disease 2019 |
4 |
|
cyclin d3 |
4 |
|
epithelium - virology |
4 |
|
ex vivo bronchi |
4 |
|
eye tissue |
4 |
|
farnesyl transferase inhibitor |
4 |
|
fludase |
4 |
|
g1/s cyclin |
4 |
|
h5n1 |
4 |
|
h5n1 influenza virus |
4 |
|
hae |
4 |
|
host response |
4 |
|
human |
4 |
|
human respiratory epithelial cell in vitro cultures |
4 |
|
human respiratory organ ex vivo cultures |
4 |
|
immunohistochemistry |
4 |
|
immunology |
4 |
|
influenza a virus, h1n1 subtype - pathogenicity - physiology |
4 |
|
influenza a virus, h5n1 subtype - pathogenicity - physiology |
4 |
|
influenza virus vaccines |
4 |
|
influenza, human - prevention & control |
4 |
|
live vector vaccines |
4 |
|
m2 |
4 |
|
maackia amurensis agglutinin |
4 |
|
medical sciences |
4 |
|
orthomyxoviridae - drug effects |
4 |
|
protein degradation |
4 |
|
protein-protein interaction |
4 |
|
recombinant fusion proteins - pharmacokinetics - pharmacology |
4 |
|
respiratory mucosa - cytology - metabolism - virology |
4 |
|
restriction factor |
4 |
|
sambucus nigra agglutnin |
4 |
|
sciences: comprehensive works |
4 |
|
sialic acid receptors |
4 |
|
statin |
4 |
|
sterol biosynthesis |
4 |
|
type ii pneumocytes |
4 |
|
type-i-like pneumocytes |
4 |
|
universal vaccine |
4 |
|
zometa |
4 |
|
airway epithelium cell |
3 |
|
animal cell |
3 |
|
animal experiment |
3 |
|
animal model |
3 |
|
antiviral susceptibility |
3 |
|
apoptosis - drug effects |
3 |
|
avian h5n1 virus |
3 |
|
bronchi - metabolism |
3 |
|
cell survival - drug effects |
3 |
|
chemokine cxcl10 - metabolism |
3 |
|
cytoprotection |
3 |
|
endothelial cell |
3 |
|
enzyme-linked immunosorbent assay |
3 |
|
ex vivo human bronchus culture |
3 |
|
ex vivo lung culture |
3 |
|
flow cytometry |
3 |
|
ginsenoside |
3 |
|
ginsenosides - pharmacology |
3 |
|
human seasonal h1n1 virus |
3 |
|
human umbilical vein endothelial cells - drug effects - immunology - pathology - virology |
3 |
|
immunologic factors - pharmacology |
3 |
|
in situ nick-end labeling |
3 |
|
inflammation mediators - metabolism |
3 |
|
influenza a virus, h1n1 subtype - pathogenicity |
3 |
|
influenza a virus, h9n2 subtype - pathogenicity |
3 |
|
ip-11 |
3 |
|
micrornas - metabolism |
3 |
|
microvascular endothelial cells |
3 |
|
mir-15b |
3 |
|
models, biological |
3 |
|
neuraminidase - chemistry |
3 |
|
pandemic h1n1pdm virus |
3 |
|
real-time polymerase chain reaction |
3 |
|
recombinant fusion proteins - chemistry - pharmacology |
3 |
|
sapogenins - pharmacology |
3 |
|
sars virus - pathogenicity |
3 |
|
severe acute respiratory syndrome - virology |
3 |
|
tissue culture techniques |
3 |
|
transfection |
3 |
|
intercellular signaling peptides and proteins |
2 |
|
neural cell adhesion molecules - metabolism |
2 |
|
proteins - genetics - metabolism |
2 |
|
receptor protein-tyrosine kinases - genetics - metabolism |
2 |
|
sertoli cells |
2 |
|
testicular cell lines |
2 |
|
testis - cytology - enzymology - metabolism |
2 |
|
tyrosine phosphorylation |
2 |
|
epidermal growth factor |
1 |
|
h1n1 |
1 |
|
inflammation |
1 |
|
resilience |
1 |
|
tolerance |
1 |
